Trial Profile
Phase I trial of DM 1992 in patients with stable Parkinson's disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Nov 2018
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- 11 Aug 2009 Results were reported in a Depomed media release.
- 11 Aug 2009 Status changed from recruiting to completed, according to a Depomed media release.
- 17 Mar 2009 New trial record.